Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Consulting Adaptive Design Strategies in Rare Oncology By Abie Ekangaki March 9, 2017 Consulting 7 Sponsor Responsibilities in Medical Device Clinical Trials By Premier Research March 8, 2017 Consulting European Medical Device Regulations: Coming Changes to the Regulatory Landscape in the EU By Premier Research March 2, 2017 Patient and Stakeholder Engagement The Future of Patient Advocacy and Orphan Drug Development: Challenges and Opportunities By Juliet Moritz February 28, 2017 Clinical ResearchPhase 1 - Phase 4 4 Phases of Biomarker Method Validation in Rare Disease Research By Premier Research February 27, 2017 Medical and Regulatory Affairs ISO Guidelines for Medical Device Trials: Ethical Considerations and Informed Consent By Premier Research February 24, 2017 Previous 1 …49 50 51 52 53 … 57 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today